Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Regenerative Medicine Aided by Nanotechnology Strategies

By BiotechDaily International staff writers
Posted on 19 Nov 2013
Nanotechnology may provide new approaches for regenerative medicine, including better ways to restore or enhance damaged tissues, according to a review article by Taiwanese researchers.

Published October 2013 in the journal Science and Technology of Advanced Materials, the study reported on the current state of knowledge on nanotechnology with a focus on stem cell biology applications. Stem cells are an important potential source for repairing injured human tissues. Researchers have found that the adhesion, growth, and differentiation of stem cells are most probably controlled by their surrounding microenvironment, which contains both physical and chemical signals. These signals include the “nanotopography” of the complicated extracellular matrix that comprises a network for human tissues.

Dr. Yang-Kao Wang and colleagues from Taipei Medical University (Taipei City, Taiwan) described in their article studies showing how this nanotopography (which includes nanosized pores, ridges, and grooves) plays critical roles in the behavior and fate of stem cells. The authors also discussed the application of nanoparticles to stem cell isolation, tracking and imaging; how to convert nanotechnology tools from two to three dimensions; and the potential limitations of using nanomaterials in stem cell biology.

The authors concluded that “understanding [the] interactions of nanomaterials with stem cells may provide knowledge applicable to [the development of improved] cell-scaffold combinations in tissue engineering and regenerative medicine.”

Related Links:

Taipei Medical University



Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.